Effectiveness of Casirivimab-Imdevimab and Sotrovimab Monoclonal Antibody Treatment among High-Risk Patients with Sars-Cov-2 Infection: A Real-World Experience. acbr [Internet]. 2023 May 10 [cited 2026 Sep. 17];7(3):325-36. Available from: https://fortunejournals.org/ojs/index.php/acbr/article/view/15015